Patent: 8,029,800
Summary for Patent: 8,029,800
| Title: | Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) |
| Abstract: | The invention relates to novel insertion sites useful for the integration of HIV DNA sequences into the MVA genome, and to the resulting recombinant MVA derivatives. |
| Inventor(s): | Paul Howley, Sonja Leyrer, Paul Chaplin, Eva Felder |
| Assignee: | Bavarian Nordic AS |
| Application Number: | US12/393,861 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,029,800
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bavarian Nordic A/s | VAXCHORA | cholera vaccine, live, oral | Suspension | 125597 | June 10, 2016 | ⤷ Start Trial | 2029-02-26 |
| Bavarian Nordic A/s | VAXCHORA | cholera vaccine, live, oral | Suspension | 125597 | December 23, 2020 | ⤷ Start Trial | 2029-02-26 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,029,800
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | E315660 | ⤷ Start Trial |
| Australia | 2003236646 | ⤷ Start Trial |
| Australia | 2003242540 | ⤷ Start Trial |
| Australia | 2007200016 | ⤷ Start Trial |
| Australia | 2008255213 | ⤷ Start Trial |
| Australia | 2009200380 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
